Bone Marrow Transplantation News

Life-preserving treatments once frequently threatened the fertility of patients with cancer.

Progress has been made across the United States to pass and implement legislative solutions to prevent and fight cancer, according to an American Cancer Society Cancer Action Network report.

Patients who underwent hematopoietic stem cell transplantation with bone marrow from unrelated donors reported better 5-year outcomes than those who received peripheral blood, according to long-term follow-up data from a randomized trial.

Adult umbilical cord blood transplantation produced lower rates of chronic graft-versus-host disease than peripheral blood transplants from matched, unrelated donors, according to a single institution study.

The University of Texas MD Anderson Cancer Center has retained its distinction as the No. 1 cancer hospital in the country.

The use of a double unit of unrelated cord blood did not significantly decrease transplantation failure in children and young adults with acute leukemia or myelodysplastic syndrome compared with using a single unit with adequate cell dose, according to the results of a randomized trial.

High-dose chemotherapy with autologous stem cell transplantation demonstrated efficacy for younger patients with newly diagnosed primary central nervous system lymphoma, according to the results of a prospective trial.

Long-term exposure to ambient fine particulate matter significantly increased risk for cancer mortality among elderly people in Hong Kong, according to study results.

ASH presented bridge grants to nine investigators.

Patients with advanced cancers frequently interpreted their prognoses differently from their oncologists, according to the results of a cross-sectional study published in JAMA Oncology.